Efficacy and Safety of Blood Flow Restriction Therapy in Knee Arthroplasty

Blood Flow Restriction (BFR) treatment is gaining attention as a method for improving recovery and muscle strength following total knee replacement surgery (TKA). This analysis combines results from studies to assess how effective and safe BFR therapy is, in postoperative settings and to highlight any possible drawbacks it may have. Studies suggest that when administered correctly BFR therapy can bring advantages to patients in terms of their recovery process, muscle strength improvement and overall health status. Several research investigations indicate that Blood Flow Restriction (BFR) therapy plays a role in enhancing post-surgery results for individuals with severe post operative muscle weakness or those who do not show improvement, with traditional treatment approaches. Despite studies showing the benefits of BFR therapy, many limitations remain, such as the differing BFR protocols used across studies, sample sizes and brief follow up periods that make it challenging to establish consistent clinical recommendations for treatment practices. Additionally, while certain research findings suggest no statistical disparities in muscle strength between BFR therapy and traditional treatments, other studies emphasize noticeable enhancements in functional abilities and patient reported outcomes. Indicating that BFR therapy may offer more than just strength restoration benefits. Considering the results and recognized constraints discussed here, we highlight the need for additional reproducible randomized controlled trials with greater sample sizes and extended follow up durations to be conducted in order to establish stronger evidence that can inform the creation of standardized BFR therapy protocols and ultimately improve patient outcomes following TKA surgery.